{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:05:40Z","timestamp":1787169940316,"version":"build-2736575974"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Central serous chorioretinopathy (CSC) is a posterior segment disease caused by macular serous detachment as a result of inflammation and oxidative stress due to hypoperfusion of choriocapillaris.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>The aim of the study was to assess the oxidant\/antioxidant balance in CSC.s<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>The plasma levels of malonyl dialdehyde (MDA), glutathione peroxidase (GSH-Px), myeloperoxidase (MPO), catalase (CAT), and xanthine oxidase (XO) were assessed in 21 patients with CSC (group S) and in 23 individuals without any eye pathology as the control group (group C). Furthermore, the disease was staged through routine opthalmologic examination as well as optic coherence tomography (OCT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      MDA levels were significantly higher in group S (25.36 \u00b1 4.51 nmol\/ml), when compared with group C (22.79 \u00b1 3.23 nmol\/ml) (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.035). In addition, the levels of CAT were significantly lower in group S (8.28 \u00b1 5.85 U\/ml) when compared to group C (14.02 \u00b1 8.61 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.014).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Prevention of the oxidative injury may be considered among the associated treatment options under the light of the changes detected in the oxidative\/antioxidative parameters.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/njcp.njcp_378_19","type":"journal-article","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T02:48:05Z","timestamp":1692586085000},"page":"64-68","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Oxidative Stress Parameters and Antioxidant Enzyme Levels in Patients with Central Serous Chorioretinopathy"],"prefix":"10.4103","volume":"24","author":[{"given":"S","family":"Urfalioglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F Alkan","family":"Baylan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"G\u00fcler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20240907","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1042\/CS20171246","article-title":"Oxidative stress and reactive oxygen species: A review of their role in ocular disease","volume":"131","author":"Ung","year":"2017","journal-title":"Clin Sci (Lond"},{"key":"R3-10-20240907","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/IAE.0000000000000837","article-title":"Risk factors for central serous chorioretinopathy A Systematic Review and Meta-Analysis","volume":"36","author":"Liu","year":"2016","journal-title":"Retina"},{"key":"R4-10-20240907","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ajo.2004.01.043","article-title":"Chronic central serous chorioretinopathy: Photodynamic therapy","volume":"137","author":"Taban","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"R5-10-20240907","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0161-6420(02)01157-0","article-title":"Acetazolamide for central serous retinopathy","volume":"109","author":"Pikkel","year":"2002","journal-title":"Ophthalmology"},{"key":"R6-10-20240907","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1442-9071.2012.02847.x","article-title":"Diagnosis and interventions for central serous chorioretinopathy: Review and update","volume":"41","author":"Quin","year":"2013","journal-title":"Clin Exp Ophthalmol"},{"key":"R7-10-20240907","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.preteyeres.2015.05.003","article-title":"Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis","volume":"48","author":"Daruich","year":"2015","journal-title":"Prog Retin Eye Res"},{"key":"R8-10-20240907","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1442-9071.2012.02848.x","article-title":"Central serous chorioretinopathy: A review of epidemiology and pathophysiology","volume":"41","author":"Liew","year":"2013","journal-title":"Clin Exp Ophthalmol"},{"key":"R9-10-20240907","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1097\/IAE.0b013e3181a3b923","article-title":"Detection of retinal metabolic stress resulting from central serous retinopathy","volume":"29","author":"Field","year":"2009","journal-title":"Retina"},{"key":"R10-10-20240907","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal Biochem"},{"key":"R13-10-20240907","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0014-5793(75)80385-1","article-title":"Malignant transformation-linked imbalance: Decreased XO activity in hepatomas","volume":"59","author":"Prajda","year":"1975","journal-title":"FEBS Lett"},{"key":"R14-10-20240907","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.preteyeres.2018.07.002","article-title":"OCT angiography and evaluation of the choroid and choroidal vascular disorders","volume":"67","author":"Borrelli","year":"2018","journal-title":"Prog Retin Eye Res"},{"key":"R15-10-20240907","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00006982-199414030-00008","article-title":"Central serous chorioretinopathy and indocyanine green angiography","volume":"14","author":"Piccolino","year":"1994","journal-title":"Retina"},{"key":"R16-10-20240907","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000310315","article-title":"Fluorescein-angiographic patterns in patients with central serous chorioretinopathy at the initial visit","volume":"205","author":"Yamada","year":"1992","journal-title":"Ophthalmologica"},{"key":"R17-10-20240907","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.ophtha.2008.01.021","article-title":"Morphologic changes in acute central serous chorioretinopathy evaluated by fourier-domain optical coherence tomography","volume":"115","author":"Fujimoto","year":"2008","journal-title":"Ophthalmology"},{"key":"R18-10-20240907","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1097\/IAE.0b013e3181be0a83","article-title":"Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy","volume":"29","author":"Imamura","year":"2009","journal-title":"Retina"},{"key":"R19-10-20240907","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1167\/iovs.14-14633","article-title":"Mitochondrial oxidative stress in the retinal pigment epithelium leads to localized retinal degeneration","volume":"55","author":"Mao","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R20-10-20240907","doi-asserted-by":"crossref","first-page":"7915","DOI":"10.1073\/pnas.90.17.7915","article-title":"Oxidants, antioxidants, and the degenerative diseases of aging","volume":"90","author":"Ames","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"R21-10-20240907","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0039-6257(00)00140-5","article-title":"The role of oxidative stress in the pathogenesis of age-related macular degeneration","volume":"45","author":"Beatty","year":"2000","journal-title":"Surv Ophthalmol"},{"key":"R22-10-20240907","first-page":"168","article-title":"Role of oxidative mechanisms in the pathogenesis of age-related macular degeneration","volume":"111","author":"Janik-Papis","year":"2009","journal-title":"Klin Oczna"},{"key":"R23-10-20240907","doi-asserted-by":"crossref","first-page":"e0203816","DOI":"10.1371\/journal.pone.0203816","article-title":"Daily zeaxanthin supplementation prevents atrophy of the retinal pigment epithelium (RPE) in a mouse model of mitochondrial oxidative stress","volume":"13","author":"Biswal","year":"2018","journal-title":"PLoS One"},{"key":"R24-10-20240907","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3945\/an.116.013177","article-title":"The age-related eye disease 2 study: Micronutrients in the treatment of macular degeneration","volume":"8","author":"Gorusupudi","year":"2017","journal-title":"Adv Nutr"},{"key":"R25-10-20240907","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00417-013-2396-2","article-title":"Serum dehydroepiandrosterone sulphate, total antioxidant capacity, and total oxidant status in central serous chorioretinopathy","volume":"252","author":"Turkcu","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R26-10-20240907","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2415-12-20","article-title":"High-dose antioxidants for central serous chorioretinopathy; the randomized placebo-controlled study","volume":"12","author":"Ratanasukon","year":"2012","journal-title":"BMC Ophthalmol"}],"container-title":["Nigerian Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_378_19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:15:16Z","timestamp":1787166916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_378_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/njcp.njcp_378_19","relation":{},"ISSN":["1119-3077"],"issn-type":[{"value":"1119-3077","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}